GUFICBIO

GUFIC BIOSCIENCES

Small Cap BSE: 509079 NSE: GUFICBIO
₹200.5
-2.4 (-1.18%)
As on 13 August, 2022 | 01:53

Gufic Biosciences Share Price

Gufic Biosciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Gufic Biosciences Share Returns

  • Over 1 Month -3.9%
  • Over 3 Month -8.14%
  • Over 6 Month -9.57%
  • Over 1 Year -7.81%

Gufic Biosciences Key Statistics

P/E Ratio 22.7
PEG Ratio 1.4
Market Cap Cr 1,944
Price to Book Ratio 7.2
EPS 9.9
Dividend 0
Relative Strength Index 42.93
Money Flow Index 50.73
MACD Signal -2.86
Average True Range 7.36

Gufic Biosciences Investment Rating

  • Master Rating:
  • Gufic Biosciences has an operating revenue of Rs. 779.16 Cr. on a trailing 12-month basis. An annual revenue growth of 59% is outstanding, Pre-tax margin of 16% is great, ROE of 35% is exceptional. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 95 which is a GREAT score indicating consistency in earnings, a RS Rating of 31 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 97 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Gufic BioSciences Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 165
  • 162
  • 172
  • 194
  • 251
  • 132
  • Operating Expenses Qtr Cr
  • 132
  • 131
  • 139
  • 158
  • 205
  • 108
  • Operating Profit Qtr Cr
  • 33
  • 32
  • 33
  • 36
  • 46
  • 24
  • Depreciation Qtr Cr
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • Interest Qtr Cr
  • 1
  • 1
  • 1
  • 2
  • 1
  • 3
  • Tax Qtr Cr
  • 7
  • 6
  • 8
  • 7
  • 10
  • 4
  • Net Profit Qtr Cr
  • 21
  • 20
  • 21
  • 23
  • 31
  • 13

Gufic Biosciences Technicals

EMA & SMA

Current Price
200.8
-2.1 (-1.03%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 206.36
  • 50 Day
  • 212.83
  • 100 Day
  • 218.85
  • 200 Day
  • 222.8
  • 20 Day
  • 204.48
  • 50 Day
  • 212.76
  • 100 Day
  • 228.84
  • 200 Day
  • 223.12

Gufic Biosciences Resistance and Support

PIVOT
₹204.62
Resistance
  • First Resistance
  • 207.59
  • Second Resistance
  • 212.27
  • Third Resistance
  • 215.24
Support
  • First Resistance
  • 199.94
  • Second Resistance
  • 196.97
  • Third Resistance
  • 192.29
  • RSI
  • 42.93
  • MFI
  • 50.73
  • MACD Single Line
  • -2.86
  • MACD
  • -2.48

Gufic Biosciences Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 327,632
  • 20,395,092
  • 62.25
  • Week
  • 275,203
  • 16,113,150
  • 58.55
  • 1 Month
  • 159,331
  • 9,618,830
  • 60.37
  • 6 Month
  • 249,021
  • 9,876,190
  • 39.66

Gufic Biosciences Result Highlights

Gufic BioSciences Synopsis

NSE-Medical-Generic Drugs

Gufic Biosciences Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 487.70 Cr. and Equity Capital is Rs. 9.69 Cr. for the Year ended 31/03/2021. Gufic BioSciences Ltd. is a Public Limited Listed company incorporated on 23/07/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1984PLC033519 and registration number is 033519.
  • Market Cap
  • 1,947
  • Sales
  • 694
  • Shares in Float
  • 2.42
  • No of funds
  • 11
  • Yield
  • 0.05
  • Book Value
  • 7.23
  • U/D Vol ratio
  • 0.6
  • LTDebt / Equity
  • 18
  • Alpha
  • -0.03
  • Beta
  • 1.3

Gufic BioSciences

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 75%
  • 75.48%
  • 75.48%
  • Mutual Funds
  • 1.03%
  • 1.03%
  • 1.19%
  • Foreign Portfolio Investors
  • 1.38%
  • 1.51%
  • 1.69%
  • Financial Institutions/ Banks
  • Individual Investors
  • 17.84%
  • 17.65%
  • 17.4%
  • Others
  • 4.75%
  • 4.33%
  • 4.24%

Gufic BioSciences Management

  • Name
  • Designation
  • Mr. Jayesh P Choksi
  • Chairman & Managing Director
  • Mr. Pranav J Choksi
  • WholeTime Director & CEO
  • Mr. Pankaj J Gandhi
  • Whole Time Director
  • Mr. Dilip B Ghosh
  • Whole Time Director
  • Dr. Balram H Singh
  • Non Exe.Non Ind.Director
  • Mr. Rabi N Sahoo
  • Independent Director
  • Mr. Gopal M Daptari
  • Independent Director
  • Mr. Shreyas K Patel
  • Independent Director
  • Mr. Shrirang V Vaidya
  • Independent Director
  • Dr. Anu S Auora
  • Independent Director

Gufic Biosciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Gufic Biosciences Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-11
  • Quarterly Results
  • 2022-05-20
  • Audited Results & Final Dividend
  • 2022-02-09
  • Quarterly Results
  • 2021-11-03
  • Quarterly Results
  • 2021-08-11
  • Quarterly Results

Gufic BioSciences MF Shareholding

  • Name
  • Amount(cr)
  • SBI Healthcare Opportunities Fund Regular Payout Inc Dist cum Cap Wdrl
  • 1668

Gufic BioSciences FAQs

What is Share Price of Gufic BioSciences ?

Gufic BioSciences share price is ₹200 As on 13 August, 2022 | 01:39

What is the Market Cap of Gufic BioSciences ?

The Market Cap of Gufic BioSciences is ₹1943.7 Cr As on 13 August, 2022 | 01:39

What is the P/E ratio of Gufic BioSciences ?

The P/E ratio of Gufic BioSciences is 22.7 As on 13 August, 2022 | 01:39

What is the PB ratio of Gufic BioSciences ?

The PB ratio of Gufic BioSciences is 7.2 As on 13 August, 2022 | 01:39

Q1FY23